Table 3.
Posttranslational modifications in NETs.
| Source of NETs | Stimulation | Enriched PTMs found in NETs | Affected PTMs in NETs | ||||
|---|---|---|---|---|---|---|---|
| Acetylation | Citrullination | Methylation | Acetylation | Citrullination | Methylation | ||
| Human peripheral | Hydrogen peroxide | H4K5Ac | H3Cit(2,18,17) | H4K20Me1/2/3 | H3K9Ac | ||
| neutrophils | H4K16Ac | H4Cit3 | |||||
| ATRA/GM-CSF | Hydrogen peroxide | H3Cit(2,8,17) | H3K9Me2 | H2BK12Ac | H3K36Me2 | ||
| differentiated murine | Ionomycin | H3Cit26 | H3K27Me1/2/3 | H3K9Ac | H4K20Me2 | ||
| EPRO cells | LPS | H4Cit3 | H4K20Me1/2/3 | H3K27Ac | |||
| PMA | H4K16Ac | ||||||
| TNF | H3R17Me2(a) | ||||||
| H4R3Me2(s) | |||||||
| ATRA differentiated | Hydrogen peroxide | H3K27Me1/2/3 | H2BK12Ac | H3Cit(2,8,17) | H3K36Me2 | ||
| human leukemia | LPS | H3K9Ac | H3Cit26 | H4K20Me2 | |||
| HL-60 cells | TNF | H3K27Ac | H3R2Me2(a) | ||||
| H3R17Me2(a) | |||||||
| H4R3Me2(s) | |||||||
Abbreviations
- K
lysine
- R
arginine
- Me
methyl
- Ac
acetyl
- Cit
citrulline
- (a)
asymmetric
- (s)
symmetric
- TNF
tumor necrosis factor
- EPRO
early promyelocyticcell line
- ATRA
all-trans retinoic acid
- PMA
phorbol 12-myristate 13-acetate
- LPS
lipopolysaccharide.